• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • COVID-19 Annoucements
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2023 Scientific Session Call For Abstracts
      • 2023 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Past Meetings
      • SAGES 2022
      • SAGES 2021
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Video Based Assessments (VBA)
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy-Coming Soon!
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • Store
    • “Unofficial” Logo Products
  • Log In

The Sufentanil Sublingual Tablet 30 mcg for Management of Post-operative Pain Following A Range of Abdominal Surgeries

Jacob Hutchins, MD1, David Leiman, MD2, Karen DiDonato, MSN, RN3, Pamela Palmer, MD, PhD3. 1University of Minnesota, 2Victoria Medical Center, 3AcelRx Pharmaceuticals

OBJECTIVE: Following completion of a comprehensive clinical program, the Sufentanil Sublingual Tablet 30 mcg (“SST 30 mcg”; DSUVIA™) was recently approved by the U.S. FDA for management of acute pain in adults severe enough to require an opioid analgesic and for which alternative treatments are inadequate.  SST 30 mcg can only be administered in a medically supervised setting such as hospitals, the Emergency Department and surgery centers and appears well-suited for short duration acute pain management because it acts rapidly, does not require an invasive route of delivery and possesses a predictable off-set. Three phase 3 trials were conducted; one randomized and placebo-controlled in post-operative abdominal patients and two open-label and single-arm intended to evaluate SST 30 mcg in the Emergency Department (ED) and in older, post-operative patients. The primary objective of this analysis was to examine the key efficacy and safety results by surgery type for patients who were treated with SST 30 mcg following various abdominal surgery procedures.

METHODS: Two of the three studies enrolled abdominal surgery patients: one randomized and placebo-controlled for up to 48 hours in adult patients undergoing laparoscopic abdominal surgery, hernia repair or abdominoplasty and the other open label evaluating SST 30 mcg in older adults (≥ 40 years) following laparoscopic abdominal or orthopedic surgery. All patients provided IRB-approved informed consent.  Efficacy was assessed by patient reports of pain intensity on an 11-point numerical rating scale (0 = no pain, and 10 = worst possible pain), with the primary outcome measure as the Summed Pain Intensity Difference to baseline over the 12-hour study period (SPID12).  Safety was assessed via vital signs, oxygen saturation monitoring, adverse events (AEs) and concomitant medications. An a priori subgroup analysis by surgery type was additionally performed to assess for potential differences in efficacy or safety.

RESULTS: A total of 161 (107 SST 30 mcg, 54 Placebo) and 140 patients, respectively were enrolled in the placebo-controlled and open-label trial.  Of those, 244 (81%) underwent abdominal surgery (laparoscopic abdominal [n=106], abdominoplasty [n=80], open hernia [53] and other [n=5].) Statistically significant LS mean SPID12 differences were observed in favor of SST 30 mcg over placebo for abdominoplasty (30.8 vs 17.6; p=0.001) and laparoscopic abdominal patients (21.4 vs 8.2; p=0.019) in the RCT.  Reductions in pain intensity were numerically greater for hernia patients assigned to SST 30 mcg compared to placebo (18.6 vs 7.7), but did not reach significance, likely due a small sample size.  In the open label study, mean pain intensity for abdominal surgery patients significantly decreased from baseline starting at 30 minutes post-dose and remained relatively stable for the duration of the 12-hour study period (P<0.001 at each time point). The most frequently reported AEs across all surgery cohorts was nausea (29.6%) and headache (9.6%) with no significant differences between active and placebo.

CONCLUSION: SST 30 mcg has shown benefit across a variety of postoperative abdominal patients as a non-invasive analgesic modality for short-term management of acute moderate-to-severe pain.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 98914

Program Number: ETP748

Presentation Session: Emerging Technology Poster Session (Non CME)

Presentation Type: Poster

View this Poster

43

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

« Return to SAGES 2019 abstract archive

Our Mission

Innovate, educate and collaborate to improve patient care.

Recently, on SAGES…

Critical View of Safety (CVS) Challenge QR Code

The SAGES Critical View of Safety Challenge – Donate Your Lap Chole Videos!

The Society of American Gastrointestinal and Endoscopic Surgeons is hosting the first Artificial Intelligence Data Challenge conducted by surgeons. The aim of this challenge is to generate a large and diverse dataset of laparoscopic cholecystectomy videos, annotated with respect to the subcomponents of the Critical View of Safety (CVS). Computer scientists from all over the […]

Respuesta de SAGES al Estudio NordICC sobre el beneficio de las colonoscopias de detección

SAGES desea aclarar los resultados del estudio NordICC y colocarlos en contexto de los esfuerzos de varias agencias nacionales para reducir el riesgo de cáncer colorrectal – la segunda causa de muerte por cáncer más frecuente en los Estados Unidos-, mediante la promoción de la detección y tratamiento oportuno de las lesiones.

SAGES Response to NordICC Study Regarding Benefit of Screening Colonoscopies

The NordICC Study recently published in The New England Journal of Medicine and widely reported on by media outlets has raised questions regarding the benefit of screening colonoscopy in lowering the risk of colorectal cancer and cancer-related deaths among otherwise healthy and symptom-free men and women aged 55 to 64. Provocative headlines and commentaries have […]

Contact SAGES

Society of American Gastrointestinal and Endoscopic Surgeons
11300 W. Olympic Blvd Suite 600
Los Angeles, CA 90064 USA
webmaster@sages.org
Tel: (310) 437-0544

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons